Zobrazeno 1 - 10
of 564
pro vyhledávání: '"Wim Van Biesen"'
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Prevention of clotting in hemodialysis (HD) is a concern, but tools to monitor anticoagulation strategies as well as data on bleeding and its impact on quality of life (QoL) are scant. In this prospective longitudinal observational study, bl
Externí odkaz:
https://doaj.org/article/cbc0139363a54c8d9c0a1dc33e6cd2e0
Autor:
Evelien Snauwaert, Stefanie De Buyser, An Desloovere, Wim Van Biesen, Ann Raes, Griet Glorieux, Laure Collard, Koen Van Hoeck, Maria Van Dyck, Nathalie Godefroid, Johan Vande Walle, Sunny Eloot
Publikováno v:
Toxins, Vol 16, Iss 8, p 349 (2024)
To promote improved trial design in upcoming randomized clinical trials in childhood chronic kidney disease (CKD), insight in the within- and inter-patient variability of uremic toxins with its nutritional, treatment- and patient-related confounding
Externí odkaz:
https://doaj.org/article/0bfac0465d854f04b277e2546986042d
Autor:
Paweł Morzywołek, Johan Steen, Stijn Vansteelandt, Johan Decruyenaere, Sigrid Sterckx, Wim Van Biesen
Publikováno v:
Critical Care, Vol 26, Iss 1, Pp 1-11 (2022)
Abstract Background and objectives Defining the optimal moment to start renal replacement therapy (RRT) in acute kidney injury (AKI) remains challenging. Multiple randomized controlled trials (RCTs) addressed this question whilst using absolute crite
Externí odkaz:
https://doaj.org/article/1689e95e632842d78f508b0ff53aa2a4
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background There is increasing interest in incorporating clinical decision support (CDS) into electronic healthcare records (EHR). Successful implementation of CDS systems depends on acceptance of them by healthcare workers. We used a mix of
Externí odkaz:
https://doaj.org/article/d6e7dc1e8bcc4a89885abfd8cbbdd277
Publikováno v:
BMC Medical Ethics, Vol 23, Iss 1, Pp 1-14 (2022)
Abstract Research regarding the drivers of acceptance of clinical decision support systems (CDSS) by physicians is still rather limited. The literature that does exist, however, tends to focus on problems regarding the user-friendliness of CDSS. We h
Externí odkaz:
https://doaj.org/article/abe4f5546dc144d89290905d9b547e65
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Previous studies revealed the importance of biocompatibility, anticoagulation strategy, and dialysis mode and duration on fiber blocking at the end of a hemodialysis session. The present study was set up in ten hemodialysis patients to relat
Externí odkaz:
https://doaj.org/article/ec7a05ca67ee49a18659572933a52b7e
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
The combination of “Big Data” and Artificial Intelligence (AI) is frequently promoted as having the potential to deliver valuable health benefits when applied to medical decision-making. However, the responsible adoption of AI-based clinical deci
Externí odkaz:
https://doaj.org/article/a917d0b1c4184034885167a7565f110d
Autor:
Jill Vanmassenhove, Johan Steen, Stijn Vansteelandt, Pawel Morzywolek, Eric Hoste, Johan Decruyenaere, Dominique Benoit, Wim Van Biesen
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Most reports on AKI claim to use KDIGO guidelines but fail to include the urinary output (UO) criterion in their definition of AKI. We postulated that ignoring UO alters the incidence of AKI, may delay diagnosis of AKI, and leads to underest
Externí odkaz:
https://doaj.org/article/ac20b3ddb47b4064a71b6eddb5599428
Autor:
Wim van Biesen, Catherine Van Der Straeten, Sigrid Sterckx, Johan Steen, Lisa Diependaele, Johan Decruyenaere
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 21, Iss 1, Pp 1-17 (2021)
Abstract Over the last decades, the face of health care has changed dramatically, with big improvements in what is technically feasible. However, there are indicators that the current approach to evaluating evidence in health care is not holistic and
Externí odkaz:
https://doaj.org/article/28045690d3444afda6e4084d64a02d20
Autor:
Matthijs Oyaert, Marie-Angélique De Scheerder, Sophie Van Herrewege, Guy Laureys, Sofie Van Assche, Melissa Cambron, Leslie Naesens, Levi Hoste, Karlien Claes, Filomeen Haerynck, Tessa Kerre, Steven Van Laecke, Wim Van Biesen, Peggy Jacques, Bruno Verhasselt, Elizaveta Padalko
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundImmunocompromised patients are at increased risk of severe COVID-19 and impaired vaccine response. In this observational prospective study, we evaluated immunogenicity of the BNT162b2 mRNA vaccine in cohorts of primary or secondary immunoco
Externí odkaz:
https://doaj.org/article/4592b193715f4244a7a62ced1cd7f9db